Factors Associated with Absolute Neutrophil Count Dynamics and Docetaxel-Adryamicin-Cyclophosphamide (TAC) Chemotherapy Induced Neutropenia During Extended Filgrastim Administration in Breast Cancer Patients
Background: Myelosuppressive effects of chemotherapy for breast cancer treatment may trigger chemotherapy-induced neutropenia (CIN) and febrile neutropenia (FN). Filgrastim has been widely used as prophylaxis against CIN and FN. However despite filgrastim administration, some study showed FN still o...
Saved in:
| Main Authors: | Ami Ashariati, Ugroseno Yudho Bintoro, Merlyna Savitri, Muhammad Noor Diansyah, Putu Niken Ayu Amrita, Pradana Zaky Romadhon, Andi Yasmin Wijaya, Winona May Hendrata, Steven Sheng Looi, Ahmad Amin Mahmudin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Interna Publishing
2022-09-01
|
| Series: | Acta Medica Indonesiana |
| Subjects: | |
| Online Access: | http://www.actamedindones.org/index.php/ijim/article/view/1956 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effectiveness of filgrastim and polyethylene glycol-filgrastim in the treatment of postchemotherapy neutropenia in children: Phase I clinical trial
by: Saeed Yousofian, et al.
Published: (2019-01-01) -
Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
by: Advani S, et al.
Published: (2010-01-01) -
Erythema multiforme secondary to filgrastim in a case of pemphigus vulgaris
by: Prachi Bhandare, et al.
Published: (2025-01-01) -
The Association between Plasma miRNA-21 Levels with Overall 1-year Survival Rate of Breast Cancer Patients at Various Stages
by: Pradana Zaky Romadhon, et al.
Published: (2022-01-01) -
Bone Mineral Density, C-Terminal Telopeptide of Type I Collagen, and Osteocalcin as Monitoring Parameters of Bone Remodeling in CML Patients Undergoing Imatinib Therapy: A Basic Science and Clinical Review
by: Nurita Indarwulan, et al.
Published: (2024-11-01)